AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03712410 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PISCES
Description: The intervention is based on Problem Solving Therapy and is a coping skills intervention designed for family caregivers of hospice patients.
Study NCT00641797 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine
Description: 25 - 50mg PO/IV once prn
Study NCT00641797 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron
Description: Ondansetron 4 - 8 mg PO/IV prn
Study NCT02389036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SDD Gastric Suspension
Description: 2. A six-hourly administration of 10 mL of a suspension containing 100 mg colistin, 80 mg tobramycin and 2 x 10 \^6 IU nystatin, to the gastrointestinal tract via a gastric/post-pyloric tube
Study NCT02389036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Antibiotic
Description: A four-day course of an intravenous antibiotic in patients not already receiving a therapeutic antibiotic
Study NCT03672292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCY-078
Description: Oral tablets of SCY-078
Study NCT00819988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: Pregabalin capsule 75 mg given preoperatively, then eith 50 mg or 25 mg given every 8 hours for 3 days postoperatively based on renal function
Study NCT00819988 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sugar pill
Description: Single dose given 30-60 minutes preoperatively, then given every 8 hours for 3 days postoperatively
Study NCT03672292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voriconazole
Description: Voriconazole IV vials or oral tablets
Study NCT03672292 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Voriconazole
Description: Voriconazole IV vials or oral tablets
Study NCT03007511 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fidmi enhanced enteral feeding device
Description: Fidmi enhanced enteral feeding device is intended to provide nutrition to a patient directly into the stomach through a stoma. The Fidmi PEG device would be investigated in this study on patients suffering from dysphagia, who are scheduled for PEG procedure in order to improve surgical initial insertion, device replacement and removal.
Study NCT04211337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Description: Administered orally
Study NCT04211337 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cabozantinib
Description: Administered orally
Study NCT04211337 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vandetanib
Description: Administered orally
Study NCT02615951 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: blood sampling
Description: Blood sample retrieval for biological and genetic analysis and comparison
Study NCT00962897 — intervention group
Intervention type: PROCEDURE
Intervention: Stent-graft placement
Description: Patients that underwent treatment of blockage in the thigh arteries with balloon angioplasty with stent-graft placement.
Study NCT00914615 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation
Description: Radiation therapy will be delivered on six occasions, over two weeks. Each treatment will take approximately 30 minutes to deliver (up to an hour including all imaging and set-up procedures). You may be asked to swallow 250 cc of oral contrast before each radiation therapy treatment. Pepto Bismol (a liquid that coats the stomach and is used to treat heartburn) and/or water may be combined with the contrast to improve the quality of the stomach's image.
Study NCT03672292 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oral Placebo Tablets
Description: Oral Placebo Tablets matching SCY-078
Study NCT05851820 — intervention group
Intervention type: OTHER
Intervention: comparison of outcomes/exposure
Description: analysing if diabetes mellitus have an impact on the primary outcomes: hospital stay, admission to the ICU, death.
Study NCT03767218 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Late follicular phase stimulation with recombinant-human FSH
Description: Start of ovarian stimulation with recombinant-human FSH (Bemfola 225 IU daily) from the late follicular phase of the menstrual cycle onwards. Start of GnRH antagonist (ganirelix 0.25mg/day) when serum LH > 10 IU/L, till day of trigger.
Study NCT03767218 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Early follicular phase stimulation with recombinant-human FSH
Description: Start of ovarian stimulation with recombinant-human FSH (Bemfola 225 IU daily) from day 2 of follicular phase onwards. Initiation of GnRH antagonist (ganirelix, 0.25mg/day) on stimulation day 6 till day of trigger.
Study NCT03862391 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Analgesics
Description: while patients are in the PACU after general anesthesia, if patients' VAS scores are higher than 3, we will give them 50 mg of deksketoprofen as analgesic.
Study NCT03862391 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antiemetics
Description: while patients are in the PACU after general anesthesia, if patient' Nausea and vomiting scores are higher than 1, we will give them 4 mg of ondansetron
Study NCT03728894 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam-hydroxyzine with 100% O2
Description: Patients received Oral Sedatives with 100% O2 ,Behavior was assessed using the modified Houpt behavioral rating scale, by evaluating the videotapes of all patients at both the pretreatment and treatment phases.
Study NCT03728894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam-hydroxyzine with 50% N2O/O2
Description: Patients received Oral Sedatives with 50% nitrous ,Behavior was assessed using the modified Houpt behavioral rating scale, by evaluating the videotapes of all patients at both the pretreatment and treatment phases.
Study NCT04804462 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Meditation
Description: After donning the VR headset, participants will be able to use a handheld controller to choose from several virtual outdoor settings, three types of meditation, and three session lengths. After choosing their desired option, participants will experience virtual reality meditation in the desired virtual location, of the desired meditation type, and for the allotted duration chosen.
Study NCT02353247 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Norethindrone acetate
Study NCT02403245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychosocial stimulation
Description: Intervention consists in a session of social stimulation during about 40 minutes through where the speaker introduced himself to the residents and introduces the residents to each others. The date of the day was done to residents. Social stimulation consists here to an exercise about the four seasons. Residents are asked to mention the 4 seasons and to give all the characteristics they can about each season. Two exercises were proposed: 4 pictures of landscapes and residents were asked to tell which season is represent on the pictures and pictures of some fruits and residents tried to tell in which season we find the fruits. Finally, the psychologist speaks about the four season of the compositor Vivaldi and propose to the residents to listen some extracts of each pieces of music.
Study NCT01411306 — intervention group
Intervention type: OTHER
Intervention: Toronto Bedside Swallowing Screening Test (TOR-BSST©)
Description: All enrolled patients will be screened for dysphagia by two blinded screeners using the TOR-BSST©.
Study NCT01411306 — intervention group
Intervention type: PROCEDURE
Intervention: Videofluoroscopic Swallow Study
Description: All enrolled patients will undergo a videofluoroscopic assessment of swallowing within 24 hours of being screened with the TOR-BSST©.
Study NCT02440386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conditional economic incentive
Description: Individuals in the intervention arm will receive the standard of care. In addition, individuals in the intervention arm receive a voucher worth R300. They are told that they will get this money if they:~1. Initiate ART at any clinic within 3 months from the time of their CD4 count test at the Tutu Tester; and~2. send a text message to the study team to let us know they have started ART;~3. Schedule a meeting with a member of the study team to show their clinic card and ARVs to confirm ART initiation.
Study NCT02178384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Altered cast technique
Description: This techniques deals with the procedures that are employed when constructing the removable partial denture on working casts.
Study NCT02178384 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Precision Attachments
Description: These are minor attachments used to split the loading forces during appliance wear
Study NCT02178384 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resilient layer
Description: This is a layer beneath the appliance which helps in reducing the transmission of loading forces to the underlying soft tissues
Study NCT02213211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artemether lumefantrine
Study NCT04116164 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 111In-DOTA-h11B6
Description: 4-6 mCi 111In labeled to 2 mg DOTA-h11B6; 0, 8 or 18 mg additional h11B6.
Study NCT01938274 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational intervention
Description: A 30-minute discussion and slide presentation with a trained member of the research team.
Study NCT03811756 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Test syrup containing CoQ10 and collagen
Description: Test group will receive investigational product - test syrup (daily dose 10 mL: fish collagen: 4000 mg, water soluble CoQ10 (Q10Vital®): 50 mg, vitamin C: 80 mg, vitamin A: 920 μg, biotin: 150 μg); continuous administration of investigational product for 12 weeks.
Study NCT03811756 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo syrup
Description: Placebo group will receive placebo syrup without active ingredients. (daily dose 10 mL: fish collagen: 0 mg, water soluble CoQ10 (Q10Vital®): 0 mg, vitamin C: 0 mg, vitamin A: 0 μg, biotin: 0 μg); continous administration of placebo product for 12 weeks.
Study NCT01946399 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ozurdex implant
Description: Intravitreal injection of Dexamethasone implant
Study NCT03179176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Frequence Ultrasound Doppler (HFUD) utilisation
Description: Utilisation of HFUD will be done during on patients during an operation in waking condition. This procedure extends the usual procedure from 15 to 20 minutes.
Study NCT02385175 — intervention group
Intervention type: OTHER
Intervention: Different objective clinical tests of Eustachian tube function
Study NCT02385175 — intervention group
Intervention type: OTHER
Intervention: Different patient-completed questionnaires relating to Eustachian tube dysfunction
Study NCT03057028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anakinra
Study NCT00925483 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: dialysis
Description: different dialysis schedules for each arm
Study NCT01418937 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CervarixTM (GSK580299)
Description: Three intramuscular injections
Study NCT03204513 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vanderbilt Powered Knee-Ankle Prosthesis
Description: The Vanderbilt powered prosthesis is a transfemoral prosthesis with powered and coordinated knee and ankle joints. The Generation 3 prosthesis is actuated by two brushless direct current (DC) motors, providing up to 100 Nm of torque at the knee joint, and with the assistance of a parallel stiffness, up to 200 Nm in plantar flexion at the ankle. Sensors measure knee and ankle joint angles, axial load in the shank, and position and orientation of the prosthesis in space (via a 6-axis inertial measurement unit). An onboard lithium-ion battery provides sufficient energy for approximately 10,000 steps between battery charges. The prosthesis prototype weighs approximately 4.3 kg (9.5 lb), the mass of which is approximately equivalent to the intact limb of a 48 kg (105 lb) person.
Study NCT03204513 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microprocessor (MP) Knee Prosthesis
Description: Participants enrolled will already have their own microprocessor controlled (MP) non-powered knee prostheses as per inclusion criteria. Examples: OttoBock's C-Leg, Ossur's Rheo, Freedom Plie, Endolite Orion,etc.
Study NCT04595864 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transarterial chemoinfusion (TAI) with mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)
Description: TAI
Study NCT02427321 — intervention group
Intervention type: DEVICE
Intervention: Video recording of flexible cystoscopic examination
Description: The video feed from the flexible cystoscopic examination will be recorded for all participants in the study. Proof-of-concept device will record high-definition video in a lossless format to a computer hard-drive from any existing cystoscopy equipment
Study NCT04306809 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered ACT for PTSD and chronic pain
Description: The participants will go through an active internet-based ACT treatment focused on education about PTSD, value-based exposure for the traumatic memory and avoided situations, and behavior change through exercises targeting the processes mindfulness, cognitive defusion and acceptance. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Study NCT00273572 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate Lifestyle Intervention
Description: Two educational group meetings with a dietitian in the first month of intervention; One individual counselling session with a dietitian at baseline, and at 6-month and 12-month follow-up
Study NCT00273572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Description: A monthly individual counselling session with a dietitian; A monthly group session with a dietitian; Bi-monthly group sessions with a physical activity instructor
Study NCT02752009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Axillary Lymph Node Sampling Clip
Study NCT01485211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cross-linking with hypo-osmolar riboflavin
Description: Hipo-osmolar riboflavin was applied every 20 seconds until the TCT reached 400µm. UVA irradiation was performed for 30 min. Pachymetry was recorded at the thinnest point of the cornea preoperatively, after epithelial removal, after iso-osmolar riboflavin, after hypo-osmolar riboflavin, after UVA irradiation, and at 1, 6 and 12 months.
Study NCT02794233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Impedance measurements
Description: Refer to study description
Study NCT01809912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human apolipoprotein(a) Kringle V
Study NCT01875146 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 4x4 min HIT
Description: Conventional 4x4 min high-intensity interval training
Study NCT03772574 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: THRIVE preoxygenation
Description: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).
Study NCT01875146 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 4x4 min HIT + WBV (18 Hz)
Description: 4x4 min high-intensity interval training in combination with whole-body vibration at 18 Hz during the active rest
Study NCT01875146 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 4x4 min HIT + (30 Hz)
Description: 4x4 min high-intensity interval training in combination with whole-body vibration at 30 Hz during the active rest
Study NCT01875146 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: whole-body vibration at 30 Hz
Description: 4x3 min whole-body vibration at 30 Hz
Study NCT04650204 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anticonvulsant Agent
Description: Given ASD
Study NCT04650204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perampanel
Description: Given PO
Study NCT04650204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04650204 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04650204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04650204 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT01851083 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous bone marrow mononuclear cells
Description: BMMNC infusion of either 6x10\^6 cells/kg or 10x10\^6 cells/kg weight.
Study NCT01851083 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Infusion
Description: Placebo infusion of 0.9% Sodium Chloride
Study NCT03017768 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Acute tryptophan depletion
Description: an amino-acid mixture will be administered without tryptophan (active comparator). After an incubation period of 5 hours esophageal sensitivity will be assessed by multimodal stimulation to evaluate the effect of depleted tryptophan levels on esophageal sensitivity
Study NCT03017768 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: an amino-acid mixture with tryptophan (placebo mixture) will be administered. After an incubation period of 5 hours esophageal sensitivity will be assessed by multimodal stimulation
Study NCT03017768 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Multimodal stimulation probe
Description: The multimodal esophageal probe allows to perform 4 types of stimulations in the esophagus (thermal, mechanical, electrical and chemical stimulation). These 4 modalities will be evaluated to assess esophageal sensitivity.
Study NCT05017467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: undefinedCentella Asiatica Extract
Description: All patients were asked about scar hypertrophy, scar tenderness, and pillar pain.~The scar assessment was performed using the Vancouver Scar Scale (VSS) at the one, three and 6 months after surgery.~Patients were asked to complete pre- and postoperative functional evaluations. The VAS score and QuickDASH test was used
Study NCT00748371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aspirin
Description: 40mg aspirin: one 40-mg aspirin capsule by mouth each morning + one Avicel capsule by mouth each evening
Study NCT00748371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aspirin
Description: 1300mg aspirin: one 650-mg capsule by mouth twice daily
Study NCT00748371 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo: one Avicel (cellulose) capsule by mouth twice daily
Study NCT04332718 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smartphone ECG
Description: Patients who are randomised to the 30-day smartphone ECG monitoring will be contacted within one month from randomisation. Patients will be taught on how to use the smartphone ECG monitoring. Patients are required to monitor their ECG 3 times a day for 30 days. Patients will be contacted during the monitoring period to assess for compliance and to ensure that the recording is done correctly.
Study NCT03940300 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fresh organic vegetables
Description: Individual participation in this program will take 12 weeks, from screening and enrollment through evaluation. Once enrolled, visits will occur on a weekly basis to ensure that participants receive each week's dose of fresh organic vegetables. At an optional Visit 13, offered 6 months after Visit 1, an additional health screening will be conducted.
Study NCT01022138 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HER2Bi-armed activated T cells
Description: Immediately after pheresis, the lymphocytes are activated with soluble monoclonal anti-CD3 antibody, which cross-links the CD3 receptors on T cells and activates them.
Study NCT01022138 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: After recovering from the last cycle of chemotherapy (approx. two-four weeks) patients will be re-staged. If there are no residual chemotherapy related toxicities, they will be given lymphodepleting chemotherapy consisting of one dose of Cyclophosphamide 1.0 gm/m2 on day -7. Appropriate anti-emetics will be given as pre-medications before the dose of Cyclophosphamide
Study NCT01022138 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory biomarker analysis
Description: The association between the \[18F\]-FDG PET/CT assessments (percent changes from baseline in SUVpeak) and immunologic biomarker changes as well as tumor response will be explored.
Study NCT04117529 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Collection of 2 blood sample : The first one at the inclusion in the study, the second one between 6 months and 9 months after the inclusion. The sample consists of 2 tubes of EthyleneDiamineTetraAcetic (EDTA) of 7 mL.